These data show that AIRE-mediated changes in epitope display by B16-F10 tumour cells can lead to the provision of CD4+ T cell helper epitopes capable of activating dendritic cells against both AIRE-specific and parental expressed epitopes of TAA such as TYRP1. This evidence concerns the gene CD4 and neoplasm.